FDA Inspection 1242024 — South Texas Blood And Tissue Center
The FDA completed an inspection of South Texas Blood And Tissue Center on May 20, 2024 in Weslaco, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 20, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Weslaco, TX (United States)